J.M Seargent
Expression of matrix metalloproteinase-10 in human bladder transitional cell carcinoma
Seargent, J.M; Loadman, P.M; Martin, S.W; Naylor, B; Bibby, M.C; Gill, J.H
Authors
P.M Loadman
S.W Martin
B Naylor
M.C Bibby
J.H Gill
Abstract
OBJECTIVES: To analyze matrix metalloproteinase-10 (MMP-10) expression in transitional cell carcinoma (TCC) of the bladder, evaluate the correlations between MMP-10 protein expression and clinicopathologic parameters, and address the viability of MMP-10 as a therapeutic target for TCC. MMP-mediated degradation of the extracellular matrix is an important factor in the pathogenesis of tumorigenesis and metastasis. METHODS: Using immunohistochemistry, the expression of MMP-10 was assessed using both tissue microarrays and whole sections of archival tissue specimens representative of all grades and stages of human bladder TCC (n = 60). MMP-10 expression was also assessed in histologically normal human bladder tissue (n = 10). The immunostaining results for MMP-10 expression were examined for correlations with tumor grade and stage. RESULTS: Unlike most MMPs, MMP-10 was localized primarily in the tumor mass as opposed to the tumor stroma and was detectable in all grades and stages of TCC. Significantly greater levels of MMP-10 protein were observed in superficial (pTa, pT1; n = 38) tumors than in normal bladder tissue (P = 0.01). In contrast to the proposed role of MMPs in tumor invasion, no significant difference was observed between muscle-invasive tumors (pT2 or worse; n = 22) and histologically normal bladder tissue (P = 0.50). MMP-10 expression showed no significant correlation with tumor grade. CONCLUSIONS: The data from our study showed that, unlike most MMPs, MMP-10 was not associated with tumor aggression or invasion. Our results suggest that MMP-10 protein levels are significantly greater in the earlier stages of TCC development.
Citation
Seargent, J., Loadman, P., Martin, S., Naylor, B., Bibby, M., & Gill, J. (2005). Expression of matrix metalloproteinase-10 in human bladder transitional cell carcinoma. Urology, 65(4), 815-820. https://doi.org/10.1016/j.urology.2004.11.016
Journal Article Type | Article |
---|---|
Publication Date | Apr 1, 2005 |
Deposit Date | Jan 9, 2013 |
Publicly Available Date | Feb 12, 2013 |
Journal | Urology |
Print ISSN | 0090-4295 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 65 |
Issue | 4 |
Pages | 815-820 |
DOI | https://doi.org/10.1016/j.urology.2004.11.016 |
Files
Accepted Journal Article
(2 Mb)
PDF
Copyright Statement
NOTICE: this is the author’s version of a work that was accepted for publication in Urology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Urology, 65/4, 2005, 10.1016/j.urology.2004.11.016
You might also like
Rationalized Computer-Aided design of Matrix Metalloprotease-Selective Prodrugs
(2017)
Journal Article
Anticancer RuII and RhIII Piano-Stool Complexes that are Histone Deacetylase Inhibitors
(2016)
Journal Article
Oncology Activity
(2016)
Book Chapter
Downloadable Citations
About Durham Research Online (DRO)
Administrator e-mail: dro.admin@durham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search